Maintenance fees coming due
Supernus Pharmaceuticals, Inc.
8 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Dec 11, 2026. Unpaid by Jun 11, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,314,790 | Sustained-Release Formulations of Topiramate In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Dec 11, 2026 | Jun 11, 2027 | Medium confidence | |
| US 11,679,090 | Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof In force Fee due Dec 20, 2026 Lapses if unpaid Jun 21, 2027 · High confidence | Supernus Pharmaceuticals, Inc. | In force | Dec 20, 2026 | Jun 21, 2027 | High confidence | |
| US 11,697,633 | Polymorphic Compounds and Uses Thereof In force Fee due Jan 11, 2027 Lapses if unpaid Jul 12, 2027 · Medium confidence | Supernus Pharmaceuticals, Inc. | In force | Jan 11, 2027 | Jul 12, 2027 | Medium confidence | |
| US 11,723,890 | METHODS OF TREATMENT USING AN mTORC1 MODULATOR In force Fee due Feb 15, 2027 Lapses if unpaid Aug 16, 2027 · High confidence | Supernus Pharmaceuticals, Inc. | In force | Feb 15, 2027 | Aug 16, 2027 | High confidence | |
| US 10,414,782 | Modulators of SESTRIN-GATOR2 Interaction and Uses Thereof In force Fee due Mar 17, 2027 Lapses if unpaid Sep 17, 2027 · High confidence | Supernus Pharmaceuticals, Inc. | In force | Mar 17, 2027 | Sep 17, 2027 | High confidence | |
| US 11,911,368 | Method of Treatment of CNS Disorders In force Fee due Aug 27, 2027 Lapses if unpaid Feb 28, 2028 · High confidence | Supernus Pharmaceuticals, Inc. | In force | Aug 27, 2027 | Feb 28, 2028 | High confidence | |
| US 11,919,889 | Derivatives of Substituted Morpholines and Uses Thereof In force Fee due Sep 5, 2027 Lapses if unpaid Mar 6, 2028 · High confidence | Supernus Pharmaceuticals, Inc. | In force | Sep 5, 2027 | Mar 6, 2028 | High confidence | |
| US 11,964,951 | Process of Making Derivatives of Substituted Morpholines In force Fee due Oct 23, 2027 Lapses if unpaid Apr 24, 2028 · High confidence | Supernus Pharmaceuticals, Inc. | In force | Oct 23, 2027 | Apr 24, 2028 | High confidence |
8 of 8 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.